Update on the national vaccine injury compensation program

被引:10
作者
Edlich, Richard F.
Son, Dana M.
Olson, Brianna M.
Greene, Jill Amanda
Gubler, K. Dean
Winters, Kathryne L.
Kelley, Angela R.
Britt, L. D.
Long, William B.
机构
[1] Univ Virginia Hlth Syst, Charlottesville, VA USA
[2] Legacy Emanuel Hosp LLP, Portland, OR USA
[3] Eastern Virginia Med Sch, Dept Gen Surg, Norfolk, VA 23501 USA
[4] Washington State Univ, Vancouver, WA USA
关键词
vaccine injury compensation program; thimerosal;
D O I
10.1016/j.jemermed.2007.01.001
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The National Childhood Vaccine Injury Act of 1986, as amended, established the Vaccine Injury Compensation Program (VICP). The VICP went into effect on October 1, 1988 and is a Federal "no-fault" system designed to compensate individuals, or families of individuals, who have been injured by covered vaccines. From 1988 until July 2006, a total of 2531 non-autism/thimerosal and 5030 autism/thimerosal claims were made to the VICP. The compensation paid for the non-autism/thimerosal claims from 1988 until 2006 was $902,519,103.37 for 2542 awards. There was no compensation for any of the autism/thimerosal claims. On the basis of the deaths and extensive suffering to patients and families from the adverse reactions to vaccines, all physicians must provide detailed information in the Vaccine Information Statement to the patient or the parent or legal guardian of the child about the potential dangers of vaccines as well as the VICP. (C) 2007 Elsevier Inc.
引用
收藏
页码:199 / 211
页数:13
相关论文
共 15 条
[1]  
[Anonymous], NATL CHILDHOOD VACCI
[2]   An assessment of thimerosal use in childhood vaccines [J].
Ball, LK ;
Ball, R ;
Pratt, RD .
PEDIATRICS, 2001, 107 (05) :1147-1154
[3]   The role of mercury in the pathogenesis of autism [J].
Bernard, S ;
Enayati, A ;
Roger, H ;
Binstock, T ;
Redwood, L .
MOLECULAR PSYCHIATRY, 2002, 7 (Suppl 2) :S42-S43
[4]   Autism: a novel form of mercury poisoning [J].
Bernard, S ;
Enayati, A ;
Redwood, L ;
Roger, H ;
Binstock, T .
MEDICAL HYPOTHESES, 2001, 56 (04) :462-471
[5]   Prevalence of autism in a United States population: The Brick Township, New Jersey, investigation [J].
Bertrand, J ;
Mars, A ;
Boyle, C ;
Bove, F ;
Yeargin-Allsopp, M ;
Decoufle, P .
PEDIATRICS, 2001, 108 (05) :1155-1161
[6]   Thimerosal and autism? A plausible hypothesis that should not be dismissed [J].
Blaxill, MF ;
Redwood, L ;
Bernard, S .
MEDICAL HYPOTHESES, 2004, 62 (05) :788-794
[7]   What's going on? The question of time trends in Autism [J].
Blaxill, MF .
PUBLIC HEALTH REPORTS, 2004, 119 (06) :536-551
[8]  
*CAL DEP DEV SERV, 2003, AUT SPECTR DIS CHANG
[9]   Childhood vaccine risk/benefit communication among public health clinics: A time-motion study [J].
Davis, TC ;
Fredrickson, DD ;
Kennen, EM ;
Arnold, C ;
Shoup, E ;
Sugar, M ;
Humiston, SG ;
Bocchini, JA .
PUBLIC HEALTH NURSING, 2004, 21 (03) :228-236
[10]  
Edlich Richard F, 2005, J Long Term Eff Med Implants, V15, P91, DOI 10.1615/JLongTermEffMedImplants.v15.i1.100